The Research Foundation of the City University of New York Patent applications |
Patent application number | Title | Published |
20140031565 | Organometallic Anti-Cancer Complexes - An anti-cancer ruthenium complex containing organometallic triruthenium with two maltol ligands is claimed. | 01-30-2014 |
20130315983 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER - The invention provides compositions with low toxicity and high bioavailability for treating cancer or for inhibiting the development of cancer | 11-28-2013 |
20130245070 | COMPOUNDS FOR ENHANCING ARGINASE ACTIVITY AND METHODS OF USING SAME - The present invention relates to a method for enhancing arginase activity in a damaged or injured cell. In other aspects, the invention provides a method for treating a disorder that can be treated by enhancing arginase activity in a human in need thereof, the method comprising administering to the human an effective amount of a compound that enhances arginase activity. Such disorders include ischemia, hypoxia, neurodegenerative disease or condition, stroke or trauma of the nervous system. In yet another aspect, the invention provides methods for promoting regeneration of a neural cell in a human in need thereof. | 09-19-2013 |
20110217217 | Nanocomposite Materials Comprising Metal-Organic-Framework Units and Graphite-Based Materials, and Methods of Using Same - The present invention relates to nanocomposite materials comprising: graphite-based material dispersed among transition metal-organic framework (MOF) units, wherein the graphite-based material is chemically linked to MOF units; wherein the graphite-based material is present in the range of about 5 wt. % to about 60 wt. % of the composite material. | 09-08-2011 |